About Us
Careers
Partner with us
Forgot password?
Sign in
Login
Login
Email
Password
Forgot your password?
Join VuMedi
Select specialty
Your main specialty
Adult & Family Medicine
Allergy, Asthma, Immunology
Anesthesiology
Cardiovascular
Dental
Dermatology
Emergency Medicine
Endocrinology
Gastroenterology & Hepatology
General Surgery
Hematology & Oncology
Infectious Disease
Medical Genetics
Nephrology
Neurology
Neurosurgery
Obstetrics/Gynecology
Ophthalmology
Oral Maxillofacial
Orthopaedics
Otolaryngology
Pathology
Pediatrics
Physical Medicine & Rehab
Plastic Surgery
Podiatry
Preventive Medicine
Psychiatry
Pulmonology
Radiation Oncology
Radiology
Rheumatology
Urology
First name
Last name
Email
Choose Password
KU ASH 2018 Review: Current Updates in Hematologic Diseases
Videos
Events
Playback speed
0.5x
0.75x
1x (Normal)
1.25x
1.5x
1.75x
2x
10 seconds
ASH December 2018 - MRD in AML - What is the Benefit / Risk Ratio Related to HCT?
By
KU ASH 2018 Review: Current Updates in Hematologic Diseases
FEATURING
Elihu H. Estey
By
KU ASH 2018 Review: Current Updates in Hematologic Diseases
FEATURING
Elihu H. Estey
191 views
March 19, 2019
0 Comments
Login to view comments.
Click here to Login
Featured Video
06:51
Insights from 2023 ASH Annual Meeting
ASH 2023 Insights: "Prevalence and Prediction of Ruxolitinib Tr…
Feat.
D. Tremblay
Featured Video
13:04
Winship Cancer Institute - Emory University
Treatment-Related Quality of Life in MF
Feat.
A. Hunter
Videos
22:39
KU ASH 2018 Review: Current Updates in Hematologic Diseases
ASH December 2018 - MDS - Top Trials and Key Takeaways
Feat.
B. Skikne
25:14
KU ASH 2018 Review: Current Updates in Hematologic Diseases
ASH December 2018 - MPN - Review and Synthesis of Recent Trials
Feat.
A. Yacoub
26:11
KU ASH 2018 Review: Current Updates in Hematologic Diseases
ASH 2018 Myeloid Neoplasms - How Recent Trials on Stem Cell Transpla…
Feat.
A. Singh
28:21
KU ASH 2018 Review: Current Updates in Hematologic Diseases
ASH December 2018 - Benign Hematolgy - Analysis of Top Trials
Feat.
P. Harris
30:39
KU ASH 2018 Review: Current Updates in Hematologic Diseases
ASH December 2018 - CLL and Indolent Lymphoma - Review of Clinical T…
Feat.
M. Hoffmann
21:22
KU ASH 2018 Review: Current Updates in Hematologic Diseases
ASH December 2018- Aggressive Lymphomas: Recent Approvals and Promis…
Feat.
A. Vallurupalli
25:51
KU ASH 2018 Review: Current Updates in Hematologic Diseases
MM - Overview of Trials Presented at ASH 2018
Feat.
A. Abdallah
06:55
KU ASH 2018 Review: Current Updates in Hematologic Diseases
ASH December 2018 - Lymphoma- Historical Perspective of CAR-T Cell T…
Feat.
F. Locke
24:51
KU ASH 2018 Review: Current Updates in Hematologic Diseases
ASH December 2018- Lymphoma - Efficacy and Safety from ZUMA 1, JULIE…
Feat.
F. Locke
14:52
KU ASH 2018 Review: Current Updates in Hematologic Diseases
ASH December 2018 - Lymphoma - Axi-cel as Standard of Care and Relat…
Feat.
F. Locke
03:50
KU ASH 2018 Review: Current Updates in Hematologic Diseases
ASH December 2018 - Myeloma - BCMA CAR T Therapy for Refractory Pati…
Feat.
F. Locke
23:37
KU ASH 2018 Review: Current Updates in Hematologic Diseases
ASH 2018 AML: Deciding Between Standard vs Investigational Therapies…
Feat.
E. Estey
05:54
KU ASH 2018 Review: Current Updates in Hematologic Diseases
ASH December 2018 - MRD in AML - What is the Benefit / Risk Ratio Re…
Feat.
E. Estey
06:26
KU ASH 2018 Review: Current Updates in Hematologic Diseases
ASH December 2018 - AML - Allogeneic Hematopoietic Cell Transplantat…
Feat.
E. Estey
14:49
KU ASH 2018 Review: Current Updates in Hematologic Diseases
ASH 2018 AML Challenges in Evaluating New Therapies: Understanding t…
Feat.
E. Estey
06:55
KU ASH 2018 Review: Current Updates in Hematologic Diseases
Lymphoma and Myeloma - Cellular Therapy, Efficacy and Safety from Top Tria…
Feat.
F. Locke
23:37
KU ASH 2018 Review: Current Updates in Hematologic Diseases
AML - Keynote - Latest updates on Standard Therapies and Investigati…
Feat.
E. Estey